Transaction in Own Shares

Summary by AI ^BETAClose X

Bellevue Healthcare Trust PLC announced on 07 November 2025 that it purchased 2,066,606 of its ordinary shares on the London Stock Exchange on 06 November 2025 at an average price of 127.73p per share. The Company intends to hold these purchased shares in treasury. Following this transaction, Bellevue Healthcare Trust now holds a total of 210,971,875 ordinary shares in treasury, with 104,180,434 ordinary shares remaining in issue, excluding those held in treasury. This share buyback activity could positively influence the company's stock price by reducing the number of outstanding shares.

Disclaimer*

Bellevue Healthcare Trust PLC

07 November 2025

Bellevue Healthcare Trust plc
Transaction in own shares

Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc.

Date of purchase:	06 November 2025
Number of ordinary shares purchased:	2,066,606
Trading venue	LSE
Average price paid per share:	127.73p

The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company holds 210,971,875 of its ordinary shares in treasury and has 104,180,434 ordinary shares in issue (excluding treasury shares).

The Company's LEI is: 213800HQ3J3H9YF2UI82

Enquiries:
Bellevue Asset Management (UK) Ltd.
Mark Ghahramani
Telephone: +44 (0) 203 326 2981

J.P. Morgan Cazenove
James Bouverat (Sales)
Telephone: +44 (0) 207 134 2224

NSM Funds (UK) Limited
Brian Smith, Ciara McKillop
Contact: bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END